MUNICH--(BUSINESS WIRE)--The committee of the newly initiated Andreas & Thomas Struengmann Award today announced the finalist selection for the inaugural 2024 award. It is the first of its kind in the ...
First-of-its-kind award recognizes HAYA CEO Samir Ounzain, Ph.D. and CTO Daniel Blessing, Ph.D. for their entrepreneurial vision in life sciences in the DACH region “It is a privilege to receive the ...
Billionaire biotech investor Thomas Struengmann is hoping that cancer therapy firm BioNTech, working with Pfizer and Fosun Pharmaceuticals, can speedily develop a coronavirus vaccine. For billionaire ...
Munich, Germany, May 27, 2025 – The Strüngmann Award selection committee today announced this year’s award finalists. The three companies and their founders highlight the exceptional and ...
The expert jury selected Dragan Grabulovski, Ph.D., Philipp Spycher, Ph.D., and Isabella Attinger-Toller, Ph.D. of Araris Biotech, from a group of outstanding life science entrepreneursThe founding ...
The selected finalists are a group of outstanding entrepreneurs in the field of biomedical research The award was established this year to honor Andreas Struengmann, M.D., and Thomas Struengmann, Ph.D ...
The selected finalists have demonstrated entrepreneurial execution and translational potential for a range of scientific approaches The winner(s) will be officially announced on July 3, 2025, and will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results